New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that a ...

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...

Type 2 diabetes mellitus (T2DM) has reached epidemic proportions ... So, understanding the pathogenesis of insulin resistance remains a major medical challenge. Figure 1: Molecular mechanisms ...

Researchers have found in a new study that elevated triglyceride-glucose (TyG) index, a marker of insulin resistance, was ...

The following is a summary of “Association of KCNJ11 E23K/rs5219 Gene Polymorphism with Type 2 Diabetes and Diabetes-Related ...

Omer S. Ashruf, from Northeast Ohio Medical University in Rootstown, and colleagues conducted a retrospective cohort study to compare the risks for hematologic cancers in patients with T2D treated ...

The researchers highlighted the importance of incorporating the Trabecular Bone Score alongside aBMD assessments for a more ...

In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

HFpEF outcomes were improved with semaglutide, compared with placebo, among patients with obesity-related HFpEF and type 2 diabetes.